News

Hillenbrand Forms Strategic Partnership with Lone Star for Acquisition

Hillenbrand Forms Strategic Partnership with Lone Star for Acquisition

Hillenbrand Engages in Major Acquisition Agreement

Translates to a Total Enterprise Valuation of Around $3.8 Billion

Hillenbrand, Inc. (NYSE: HI) has entered into a strategic agreement with Lone Star Funds for an all-cash acquisition valued at $32.00 per share. This deal reflects a total enterprise valuation close to $3.8 billion, marking a significant development in Hillenbrand's corporate journey. This transaction, representing a roughly 37% premium over Hillenbrand's closing stock price prior to this announcement, is poised to enhance shareholder value substantially.

Strategic Benefits of the Acquisition

The acquisition positions Hillenbrand to both solidify its current offerings and accelerate its expansion into new markets. Hillenbrand, well-regarded in providing highly-engineered processing equipment and solutions, operates through its Advanced Process Solutions and Molding Technology Solutions segments. Over the past few years, significant transformations have been evident as Hillenbrand streamlined operations and fortified its industrial food equipment portfolio through strategic acquisitions and divestitures.

Leadership Insights on the Acquisition

Helen Cornell, Chairperson of the Board of Directors, expressed optimism about the agreement, stating, "This arrangement provides immediate cash value to our shareholders at an attractive premium. We are dedicated to fulfilling our customer's needs with mission-critical processing equipment and solutions, which this partnership will enable us to do more effectively." With the approval of the Board of Directors, this deal assures a thorough consideration of various strategic alternatives before finalizing this acquisition.

Furthermore, Kim Ryan, President and CEO of Hillenbrand, articulated confidence in the alignment with Lone Star. He mentioned that the firm recognizes Hillenbrand's progress as it transitions into a pure-play industrial company. The anticipated collaboration aims to bolster growth and innovation within essential markets, including durable plastics, food, and recycling.

Lone Star's Perspective and Future Prospects

Donald Quintin, CEO of Lone Star, detailed their excitement about partnering with Hillenbrand, describing the company as a robust operator in the industrial equipment domain. Lone Star's expertise in related manufacturing sectors positions them well to enhance Hillenbrand's management team. This partnership aims to empower Hillenbrand's operational capabilities, nurturing future growth opportunities.

Transaction Details and Timeline

The transaction is expected to conclude by the end of the first quarter of the upcoming calendar year, following standard closing conditions, including shareholder approval and requisite regulatory endorsements. Once the acquisition is finalized, Hillenbrand will transition into a privately-held entity, resulting in its shares no longer being available for trading on the New York Stock Exchange.

In light of this announcement, Hillenbrand intends to issue a press release concerning its fourth quarter and fiscal year 2025 earnings but will omit holding a traditional conference call to discuss these results. Additionally, no financial guidance will be provided for fiscal year 2026.

Advisory Teams Involved in the Acquisition

Facilitating the acquisition are significant advisory teams that ensure a smooth transaction process. Evercore acts as Hillenbrand's financial advisor, while prominent law firm Skadden, Arps, Slate, Meagher & Flom LLP provides legal counsel. Simultaneously, Jefferies LLC and UBS Investment Bank serve as financial advisors for Lone Star, joined by Kirkland & Ellis as legal counsel.

About Hillenbrand Inc.

Hillenbrand is recognized as a global leader in industrial manufacturing, offering essential equipment and solutions. The company prioritizes innovation, collaboration, and excellence, striving to meet and exceed the expectations of its customers in various sectors such as durable plastics and food processing. Committed to shaping future innovations, Hillenbrand remains focused on initiatives that propel growth and adaptability in a rapidly evolving market.

About Lone Star Funds

As a prestigious investment firm, Lone Star specializes in private equity, credit, and real estate investments on a global scale. Leveraging over three decades of expertise, Lone Star navigates complex scenarios to identify promising investment opportunities regardless of market conditions. The partnership with Hillenbrand envisions further empowering the company's trajectory, ultimately benefiting shareholders and positioning Hillenbrand prominently within the industry.

Frequently Asked Questions

What is the value of the acquisition agreement involving Hillenbrand?

The acquisition deal is valued at $32.00 per share, amounting to an enterprise valuation of approximately $3.8 billion.

How does this acquisition benefit Hillenbrand?

This acquisition allows Hillenbrand to deliver immediate cash value to shareholders, foster growth, and enhance its operational capabilities in critical markets.

What segments does Hillenbrand operate in?

Hillenbrand provides solutions through its Advanced Process Solutions and Molding Technology Solutions segments, focusing on industrial equipment for various applications.

What will happen to Hillenbrand's shares post-acquisition?

Following the completion of the acquisition, Hillenbrand will become a privately-held entity, and its shares will no longer be traded on the New York Stock Exchange.

Who are the advisors involved in this transaction?

Evercore is the financial advisor for Hillenbrand, while Jefferies LLC and UBS Investment Bank serve as financial advisors for Lone Star. Skadden, Arps, Slate, Meagher & Flom LLP and Kirkland & Ellis are the legal advisors respectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 86

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oral Semaglutide Curbs Heavy Drinking: CU Study Insights

Updated Category News Views 12

New Frontiers in Tackling Alcohol Use Disorder Diabetes meds aren't just boxing in sugar levels; they're taking swings at alcohol cravings, too. The University of Colorado Anschutz threw their hat in the ring with a study that put oral semaglutide—usually in the diabetes and weight loss circuit—to a different test. Turns out, it's packing a punch against heavy...

Continue Reading
Julie Van Kleeck Strengthens Leadership at Paragon Space

Updated Category News Views 121

Julie Van Kleeck Joins Paragon Space Development Corporation Board Paragon Space Development Corporation (Paragon) proudly announces the appointment of Julie Van Kleeck to its Board of Directors. With a remarkable background in the space technology sector, Julie is set to enhance Paragon's mission with her extensive market insights and solid operational experience. Rich...

Continue Reading
Exploring Advanced Techniques for Fracture Healing in Orthopaedics

Updated Category News Views 302

Micromotion Nailing for Enhanced Fracture Healing OrthoXel is thrilled to announce an important presentation by Dr. Hannah Dailey, Co-Founder and Chief Scientific Officer, focusing on the innovative technique of micromotion nailing aimed at accelerating fracture healing. This presentation will be highlighted at an esteemed meeting gathering leading experts in the field of...

Continue Reading
Resilient Job Market Gains Amid Signs of Slowing Growth Ahead

Updated Category News Views 191

Overview of Recent Labor Market Trends The US economy has shown unexpected strength, adding more jobs than anticipated recently, instilling fresh optimism regarding the labor market's near-term stability. With political changes on the horizon, the economy's performance under the new administration remains a topic of interest. Nonetheless, we can assert that the incoming...

Continue Reading
MD Hyperbaric Expands Presence in Key U.S. Markets

Updated Category News Views 6

Expanding the Oxygen Therapy Frontier When you're talking about healing that's both ancient and cutting-edge, hyperbaric oxygen therapy (HBOT) kind of steals the show. MD Hyperbaric, calling the shots since 2021, is breaking new ground in San Antonio, Las Vegas, and Rochester. Why This Matters HBOT isn't just another fancy healthcare fad. We're seeing a real push toward...

Continue Reading